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ABSTRACT 
Halcomb, Meredith Ellen. M.S. Purdue University, May 2013. Lithium Effects on Ethanol
Intake in Impulsive Mice. Major Professor: Nicholas J. Grahame. 
The present study sought to identify the effects of chronic lithium administration on 
ethanol intakes in high alcohol-preferring (HAP) mice. Lithium is a well-established treatment for 
bipolar disorder and has demonstrated efficacy in reducing impulsivity, an endophenotype of 
the disease. Impulsivity is also a prominent trait of alcoholism. HAP mice display a preference for 
consuming substantial amounts of ethanol and exhibit abnormally high levels of impulsivity. 
Previous work has determined that chronic lithium exposure in HAP mice reduces their levels of 
impulsivity. The present study analyzed fluctuations in established intake patterns after lithium 
exposure and how pre-exposure to lithium would affect ethanol intake acquisition. The results 
showed an increase in ethanol intake and no change in preference for ethanol over water in 
lithium treated mice. There was an increase in overall total fluid consumption in these mice, 
likely resulting from polydipsic effects. There also appeared to be a potentiated lithium toxicity 
effect found in those mice pre-exposed to lithium. The conclusion was that lithium therapy does 
not decrease ethanol consumption in HAP mice. 
1 
INTRODUCTION 
For over a century, lithium has been a standard treatment for patients suffering from a 
wide range of illnesses. It was first prescribed to treat mania in 1871 at Bellevue Hospital in New 
York (Shorter, 2008). In the time since, it has fallen in and out of favor as medical trends evolved 
and other medications became available. Lithium, however, has been studied for treatment in 
bipolar and unipolar disorder numerous times and continues to have proven efficacy. In 1973, 
Prein and colleagues demonstrated that patients who were prescribed lithium when released 
from the hospital after a manic episode had only a 31% relapse rate compared to 67% in 
placebo at one year. A 5-year prospective study to determine the long-term effects of lithium 
revealed that patients who had maintained their medication scored better on diagnostic scales 
and had fewer hospitalizations than patients who had discontinued use (Maj, 1998). A review 
done in 2004 evaluated data from 5 separate randomized control trials and concluded that 
lithium is effective at reducing the risk of manic relapse and also has a clear preventative effect 
against manic episodes (Geddes, 2004). 
Bipolar disorder is also highly correlated with lifetime diagnoses of alcohol or drug 
addictions or abuse (Cassidy, 2001). Patients with bipolar disorder are 4.6 times more likely to 
have comorbid alcoholism than subjects without bipolar disorder (Winokur, 1998). Winokur 
(1994) showed that the average age for patients with comorbid bipolar disorder and alcoholism 
was 20, while the age of onset for patients with primary bipolar disorder only was 25. Further 
research revealed that a family history of mania was correlated with elevated prevalence rates 
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of bipolar disorder with comorbid alcoholism (Winokur, 1995). There is a correlation between 
age of onset of alcoholism and the course of bipolar disorder itself. Earlier onset of bipolar 
disorder is more likely to be associated with later substance abuse than later onset bipolar 
disorder (Feinman & Dunner, 1998).   
There is also evidence that patients with comorbid alcoholism are more likely to have 
repeating manic episodes. It was found that patients with comorbid alcoholism had a 100% 
relapse rate, while patients without any substance abuse problem had a relapse rate of only 
33% at a four year follow-up (Tohen, 1990).   
More recent studies have begun to evaluate possible underlying connections between 
bipolar disorder and alcoholism. One of the main facets of bipolar disorder is impulsivity. 
Holmes (2009) found that subjects with bipolar disorder comorbid with alcoholism were more 
impulsive than both healthy controls and subjects with bipolar disorder without comorbid 
alcoholism. In this study, bipolar patients and controls were given both the Barratt 
Impulsiveness Scale (BIS) and the Balloon Analogue Risk Task (BART). These tasks are commonly 
utilized in studies to assess impulsivity in humans. The scores of the bipolar patients were 
significantly elevated compared to controls on both measures. Even in euthymic states (neither 
manic nor depressed), bipolar patients that are alcoholics are more impulsive than bipolar 
individuals that are not alcoholics (Swann, 2004). 
Moeller (2001) found that there is an association between impulsivity and several 
psychiatric disorders, including bipolar disorder. Heightened levels of impulsivity are evident 
across all states of the disorder, indicating that it is a trait dependent quality, rather than a state 
dependent aspect (Swann, 2001; Peluso, 2007; Swann, 2003). Bipolar patients consistently have 
higher scores on the Barratt Impulsiveness Scale (BIS) compared to healthy controls, regardless 
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of whether they are in a manic or depressive episode. These studies lead to the conclusion that 
impulsivity is an endophenotype of bipolar disorder. It is a stable, measureable, heritable aspect 
of the disease which can be used to study and develop treatments for bipolar disorder. 
  Impulsivity is present across all subtypes of bipolar disorder and is consistently 
decreased by lithium treatment as measured by psychiatrists in hospitalized patients (Swann, 
2002). Lithium has, in fact, been shown to reduce impulsivity in individuals with bipolar disorder 
and other behavioral disorders. It reduces impulsivity levels in patients with Attention-
Deficit/Hyperactive Disorder (Dorrego, 2001). Sustained-release lithium is also effective in 
reducing impulsivity in gamblers with bipolar disorder, diminishing the severity of gambling 
when impulsivity of gambling is being studied (Hollander, 2005).   
One possible effect of lithium is a reduction of impulsivity levels. Suicidal behavior is a 
significant risk associated with bipolar disorder and, in treatment, patients treated with lithium 
are less likely than patients being treated with other medications, such as Valproate, to attempt 
suicide (Kovacsics, 2009). It has also been shown to be more effective than atypical 
antipsychotics at reducing suicidal behaviors (Ahearn, 2012). Since impulsivity is highly 
associated with suicide attempts, it can be inferred that lithium is reducing these attempts by 
decreasing impulsivity in the patients (Kovacsics, 2009). 
On a neurobiological level, it has been determined that low levels of CSF 5 – HIAA (a 
metabolic product of serotonin) lead to higher levels of impulsivity in mice (Nelson, 2001; 
Ramobz, 1996). These effects are seen primarily in areas of the brain associated with emotional 
regulation such as the limbic regions. Studies using animal models have demonstrated that 
lithium acts to increase levels of serotonin and its release in these brain regions after long-term 
treatment (Carli, 1997), suggesting a possible mechanism for lithium’s therapeutic effects on 
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impulsivity. There is also evidence that a polymorphism in GSK-3, which codes for an enzyme 
that is a target for mood stabilizers, has effects on sensitivity to lithium treatment, further 
associating lithium treatment with the serotonin system and impulsivity (Numajiri, 2012).  
There have been few experiments using animal models to investigate lithium effects on 
impulsivity. However, a recently completed study in our lab showed that daily consumption of 
lithium chow led to a reduction in impulsivity as measured by the delay discounting task in the 
selectively bred High Alcohol Preferring (HAP2) mouse line (Halcomb, Gould & Grahame, in 
press). Delay discounting is a measure of cognitive impulsivity. Mice receiving lithium chow 
showed significantly lower levels of impulsivity compared to mice in the control group, which 
received regular chow. 
Impulsivity also has a well-known association with alcoholism and substance abuse.  
Both human studies and animal models have demonstrated this link (Vuchinich, 1998; Mitchell, 
2005; Wilhelm, 2007). There is evidence that a family history of alcoholism may predict higher 
rates of impulsivity. Subjects whose family histories contain alcoholism have higher false alarm 
rates in a GoNoGo task, a measure of impulsivity (Saunders, 2008). 
 It has also been shown that prospective studies of impulsivity may be used to predict 
alcohol abuse. Murphy and Garavan (2011) evaluated 89 college students in a delay-discounting 
task and found that high impulsivity scorers also scored high on the Alcohol Use Disorders 
Identification Test (AUDIT). Individuals who have histories of alcohol abuse or are currently 
abusing alcohol are more likely to steeply discount rewards, displaying more cognitive 
impulsivity (Bjork, et al., 2004; Vuchinich & Simpson, 1998). Another study compared cognitive 
impulsivity and motor impulsivity using abstinent alcoholics and healthy controls. They found 
that the alcoholics did not differ from controls on motor impulsivity, but there were significant 
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differences in cognitive impulsivity, which contradicts findings in animal literature (Mitchell, 
2005; Ohmura, 2011).  
Studies evaluating substance abuse and impulsivity in human subjects generate 
information on correlating factors, but fail to provide causality. For example, all the previously 
cited studies could indicate either that those who are predisposed towards impulsive behavior 
are more likely to have drug abuse problems or it could indicate that a history of drug or alcohol 
use causes impulsivity. Using animal models allows for causal inferences about impulsivity and 
drug taking.  
There has been a great deal of research using animal models to characterize impulsivity. 
Alcohol-preferring inbred strains of mice also show increased impulsiveness (Wilhelm, 2007). 
Oberlin and Grahame (2009) demonstrated that High Alcohol-Preferring, alcohol-naïve (HAP) 1 
and HAP 2 mice are also more impulsive than Low Alcohol-Preferring (LAP) 1 and HS/Ibg 
(progenitor line) mice. They showed a steeper discounting curve in alcohol-naïve HAP1 and 
HAP2 mice. These studies lend credence to the concept that impulsivity is an endophenotype of 
alcoholics and that there may be a genetic link between impulsivity and alcoholism. Since this 
endophenotype of impulsivity exists in both bipolar disorder and alcoholism and lithium reduces 
this effect in both populations, I hypothesize that lithium treatment should also have an effect 
on alcohol consumption. 
Research into lithium effects on alcohol intake have produced mixed results in both 
human and animal model studies. While some clinical trials have established that lithium 
therapy decreases drinking episodes, others have found no significant difference in intake 
(Wren, 1974; Fawcett, 1987; Lejoyeux, 1993). All of these studies were done with depressed 
subjects, which may have influenced the data. Relatively few studies have evaluated lithium 
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effects on intake of other substances, but it has been shown to have no effect on cocaine 
craving and administration or rewarding effects of opioids (Gawin, 1984; Bolanos, 1996). 
The results from animal models have been no more definitive. Alexander and Alexander 
(1977) Found that Wistar-NTRU rats injected with lithium carbonate and given free choice 
between tap water and a 10% ethanol solution increased their total fluid intake, but drank less 
alcohol than controls (Alexander, 1977). Other studies have not demonstrated this effect (Hines 
1986; Hines 1988).  
 The following study was comprised of two separate experiments. Given the findings that 
lithium is effective at reducing levels of impulsivity in HAP mice, the fact that heightened 
impulsivity is a prominent trait in both bipolar disorder and alcoholism and the high co-
morbidity rate between the two disorders, Experiment One was employed to evaluate the effect 
of lithium on ethanol consumption in HAP mice which have acquired an established drinking 
pattern. Mice in this experiment were exposed to ethanol for three weeks to acquire a 
consistent drinking pattern then lithium chow was added to their cages for two weeks. It was 
hypothesized that lithium treatment would reduce ethanol intake and preference for ethanol 
over water. 
  There is evidence that separate neural circuits are involved in maintenance of ethanol 
consumption versus drinking acquisition (Ikemoto, 1997). It is possible that lithium may act 
differently in these two pathways. In addition, HAP mice are selectively bred to consume 
significant amounts of ethanol and to prefer ethanol over water. These traits may blunt the 
ability for lithium to decrease ethanol intake once those drinking patterns have been 
established. For these reasons, Experiment Two was devised to assess the efficacy of lithium in 
the prevention of acquisition of ethanol intake. In this experiment, mice received lithium 
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treatment for two weeks prior to the onset of ethanol exposure. It was hypothesized that 
lithium treatment would hinder the initiation of ethanol consumption. 
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METHODS 
 
Experiment 1 
 
Subjects 
Subjects were 24 female and 24 male HAP II mice. They were individually housed on a 
reverse light/dark cycle with lights out at 8:30 am and lights on at 8:30 pm. 
 
Experimental Design 
Mice were initially divided into two groups, balanced across sex, age and family, an 
ethanol group (E), and a water group (W). During Phase I, the ethanol group was given a two 
bottle choice, free access to tap water and 10% ethanol in tap water. The ethanol solution was 
available in a 50ml tube and water was placed in a 25ml tube. Tubes were side-switched at 
every intake reading to control for side preference. Intakes were measured three times a week. 
The water group was given water in 50ml and 25ml tubes. These were also side-switched at 
each reading. In addition, each animal was given a bottle of 9g NaCl/L tap water in glass bottles 
placed on the opposite side of the cage to help maintain isotonic balance. 
During Phase II, after 3 weeks of continuous access to alcohol, g/kg/day ethanol intakes 
were calculated for the last three days of ethanol exposure and mice were separated into four 
groups: lithium chow/ethanol (LE), lithium chow/water (LW), control chow/ethanol (CE) and 
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control chow/water (CW), with each group receiving the same liquid as Phase I. The regular 
chow was removed from the cages and was replaced with either a 4% lithium chloride or control 
chow (Custom Animal Diets, Bangor, PA). All mice were weighed three times per week to ensure 
they were not losing an unhealthy amount of weight on the lithium diet. Intakes were taken 
three times per week. Phase II lasted for 2 weeks (Fig 1). 
 
Experiment 2 
 
Subjects 
 Subjects were 18 female and 18 male HAP I mice. They were individually housed on a 
reverse light cycle with lights out at 8:30 am and lights on at 8:30 pm. 
 
Experimental Design 
 In this study, mice were separated into two groups, balanced across sex, age and family. 
For the first 2 weeks of the experiment, the lithium group was given chow containing 4% lithium 
chloride while control group were given control chow. They also had ad libitum access to water. 
Water was available in both 50ml and 25ml tubes. The sides the tubes were available on were 
switched at every intake reading. They were weighed twice weekly as lithium may cause 
unhealthy weight loss. Each cage was also given a 9g NaCl/L tap water solution in glass bottles to 
help maintain isotonic balance during lithium exposure.  
 After 2 weeks of access, when lithium had built up to therapeutic levels, the lithium and 
control chow groups were each divided into ethanol or water groups. The lithium/ethanol (LE) 
and control chow/ethanol (CE) groups had a 10% ethanol in tap water solution replaced the tap 
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water in the 50mL tubes. The lithium/water (LW) and control chow/water (CW) groups 
continued with tap water on their cages. Intakes were measured three times weekly. They were 
to remain on their lithium diets for 3 weeks with ethanol access. Hereafter these groups will be 
identified as LE, CE, LW and CW (Fig 1). 
 
Statistics 
 In Experiment 1, a two factor ANOVA was used to analyze total fluid consumption 
differences between the four groups in Experiment 1 both before and after lithium exposure 
using both fluid and group as the independent variables. Follow-up t-tests were used to identify 
differences in total fluid consumption between each group. In addition, a two factor ANOVA was 
also run on water intakes using both fluid and group as independent variables, with associated 
follow-up t-tests used to uncover differences between specific groups.   
 Further repeated measures ANOVAs were used to evaluate differences between LE and 
CE groups in g/Kg/day, preference for ethanol over water, total fluid consumption, ethanol 
intakes in mL and water intakes in mL, with chow type as the independent variable. A separate 
repeated measures ANOVA was run to determine if sex differences existed in g/kg/day intake or 
total fluid consumption. Independent t-tests were run to identify any differences in weight 
between the LE, LW, CE and CW groups.  
 In Experiment 2, independent t-tests were run to analyze weight differences between 
the lithium and control chow groups during Phase I and a two factor ANOVA was used to 
evaluate weight differences between all groups in Phase II using both fluid and chow as 
independent variables. An independent samples t-test was also used to identify differences in 
g/kg/day intake of ethanol between the LE and CE groups.  
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RESULTS 
 
Experiment 1 
  The two factor ANOVA analyzing total fluid consumption found no effect of chow or 
fluid during Phase I of the experiment, with all groups consuming similar amounts of total fluid. 
There was a main effect of day, F(9,378) = 12.86, p < 0.001, with all groups increasing total fluid 
consumption over the course of Phase I (Fig 2). 
 During Phase II, a two factor ANOVA found a main effect of chow, with LE and LW 
groups both consuming significantly more total fluid than both CE and CW groups, F(1,42) = 
11.40, p < 0.001. There was also a main effect of day in the LE and LW groups for total fluid 
intake, F(7,45) = 6.99, p < 0.001, with mice in both groups significantly increasing total fluid 
intake over the course of Phase II (Fig 2). There was no interaction of day and fluid type on total 
fluid consumption. This indicates that increases seen in total fluid consumption in the LE group 
were the result of increases in both ethanol and water intakes. There was no significant 
difference between the LE and LW groups on total fluid consumption. Although an ANOVA 
analyzing water intakes in the LW and CW mice found no main effect of chow during Phase II, 
there was an interaction of chow by day, F (7,154) = 2.134, p = 0.043. A follow-up independent 
samples t-test found that by 32 of the experiment, mice in the LW condition were consuming 
significantly more water than mice in the CW group, t(22) = -2.304, p = 0.031 (Fig 3). One 
interpretation of these results would be that the higher intakes seen in the LE and LW groups 
were driven by thirst, since lithium is known to create polydipsia. 
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 Prior to lithium exposure (Phase I), there was no significant difference between the 
lithium and control chow groups on g/kg/day intake of ethanol. A repeated measures ANOVA 
found a main effect of day for both chow groups during this pre-exposure phase (Phase I), F 
(9,180) = 13.12, p < 0.001, with intakes increasing over the three weeks, with mice in both LE 
and CE groups showing over 94% preference for ethanol over water (Fig 4). In addition, there 
was a main effect of day on preference for ethanol over water, F(9,180) = 22.97, p < 0.001, with 
an escalation of preference as Phase I progressed . Over the course of Phase I, mice acquired a 
preference for ethanol over water and increased their consumption significantly (Fig 5). At the 
end of Phase I, mice were separated into lithium and control chow groups such that there were 
no significant differences between the LE and CE groups on any of these measures. 
 Although it was hypothesized that there would be a decrease in g/kg/day ethanol 
intakes for mice in the LE group after lithium exposure (Phase II), a repeated measures ANOVA 
found a significant main effect of day for this group, F(7,140) = 7.482, p < 0.001 (Fig 6), but it 
was not in the direction it was hypothesized to be. Contrary to the prediction, mice in the LE 
group elevated their ethanol intake rather than reducing it. In addition, the g/kg/day intakes for 
the lithium chow mice were significantly higher than the g/kg/day of the control chow mice, F 
(1,20) = 1357.71, p < 0.001 (Fig 6).  
 The preference for ethanol over water observed in Phase I did not weaken during Phase 
II. A paired samples t-test revealed no significant difference in preference for ethanol over water 
in either the LE or CE group, nor was there a significant difference between the two groups (Fig 
7). 
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 Although subjects in the LE and LW groups initially lost weight at the initiation of lithium 
exposure, their weights quickly rebounded and by the end of the experiment there were no 
significant weight differences between the LE, LW, CE and CW groups (Fig 8). 
 There were also no main effects of sex seen on total fluid consumption, ethanol intakes 
or preference for ethanol over water. 
 
Experiment 2 
 Mice in the LE group in this study suffered from extreme weight loss and ill health after 
initiation of ethanol exposure. This study was terminated one week early and only weight data 
and ethanol intakes for two days were analyzed. Mice in the LW condition also weighed less, 
they did not drop below 80% of baseline weight, which have required removal from the 
experiment.  
 A t-test analyzing the ethanol intakes in g/kg/day for the two days of measurement 
available found a significant difference in the LE and CE groups, t(16) = -3.342, p < 0.001 (Fig 9). 
Subjects in the LE group consumed significantly higher amounts of ethanol during these two 
days. There was also a significant difference in water consumption between the CE and LE 
groups, t(16) = -2.237, p = 0.04. 
 A repeated measures ANOVA found a main effect of day on weight, F(4,136) = 10.04, p < 
0.001 (Fig 10). Although there was no main effect of group on weight, there was a group X day 
interaction, F(4,136) = 7.64, p < 0.001. Follow-up t tests found a significant difference in weights 
between the two groups beginning on day 4 of lithium exposure (Phase I), t(34) = -2.16, p = 0.04. 
Within one week, mice in the LE condition had severely deteriorated in health and the 
experiment was terminated.  
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DISCUSSION 
 
 In Experiment 1 in this study, mice were separated into water and ethanol groups then 
exposed to ethanol for three weeks to establish a consistent intake pattern (Phase I). They were 
separated into control and lithium chow groups based on mean ethanol intakes in grams per 
kilogram for the final three days of Phase I. At lithium induction (Phase II), both groups in the 
ethanol condition were consuming approximately 20 g/Kg of 10% ethanol solution and 7 ml of 
tap water per day. Over the course of the lithium treatment, mice in both lithium groups 
steadily increased consumption of both ethanol and water. Intakes increased to a mean of 26 
g/Kg/ day of ethanol and 9 ml/day of tap water. These consumption levels were significantly 
higher than their pre-exposure intakes and the intakes of mice in control chow groups. Although 
the first hypothesis of this study posited that lithium treatment would reduce ethanol intake, 
the results do not support that conclusion. 
 Consistent with previous findings, this study suggests that treatment with lithium 
creates polydipsia, resulting in an increase of total fluid consumption (Alexander, 1978). It is 
possible that the mice in the LE group increased their intake of ethanol due to its rewarding 
effects; however three lines of evidence counter this argument. First, there was no significant 
group by fluid interaction. Increases in ethanol intake were accompanied by increases in water 
intake. Within one week of lithium treatment (Day 32 of the experiment), mice had significantly 
increased both water and ethanol consumption. Second, mice in the LW group increased their 
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water intake compared to Phase I such that their total fluid consumed matched total fluid 
consumed in the LE group during Phase II. This indicates that the nature of the fluid was not a 
motivating factor in the escalation of consumption. In addition, there was no significant increase 
in ethanol or water intake in either of the control chow groups. The subjects in the CW group 
did not significantly increase their water intakes, while subjects in the CE group maintained 
stable consumption levels throughout Phase II, rather than increasing consumption due to 
rewarding effects. These results indicate that increases in ethanol intake were consistent with 
non-specific polydipsic effects. 
 Subjects also displayed a statistically significant preference for ethanol over water in 
Phase I which was not decreased by lithium treatment. Since the preference level was so high 
during Phase I, there was likely a ceiling effect limiting analysis of whether or not lithium 
treatment could actually increase preference for ethanol over water. Prior to lithium exposure, 
95% of the total fluid consumed by mice in the LE condition was ethanol. This preference was 
not significantly reduced by lithium. It was also not significantly different from the preference 
exhibited in the CE condition. The mice in this study are selectively bred to prefer and consume 
high amounts of ethanol and the lithium treatment did not alter this behavior. The conditioned 
taste aversion often seen with lithium exposure due to its gastrointestinal effects was not seen 
here, presumably because the mice had already formed positive associations during the ethanol 
pre-exposure in Phase I, thereby preventing a negative association from developing between 
ethanol intake and nausea.  
 This preference for ethanol over water is contradictory to previous findings in Wistar 
rats exposed to lithium carbonate which showed increased total fluid consumption but 
decreased consumption of ethanol (Alexander, 1978). Rats in that study were given 
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intraperitoneal injections of lithium carbonate rather than exposure through chow. Other 
findings of ethanol preference reduction also involved injection of lithium carbonate or chloride 
(Zakusov, 1978; Ho, 1975; Sinclair, 1974) In contrast, lithium exposure through graduated 
methods, such as drinking water or chow, resulted in no decrease in ethanol intake or 
preference (Hines, 1986; Hines, 1988). This suggests that the decrease in preference observed in 
injection studies may be a result of a negative association between the injections and ethanol 
exposure or a conditioned taste aversion rather than lithium action.  
 The results from Experiment one do not support the hypothesis that lithium treatment 
reduces ethanol intake. It is possible that we were unable to detect effects due to the 
polydipsia-induced increases in total fluid consumption; however, this seems unlikely since the 
preference for ethanol after lithium exposure was not significantly altered. Future studies could 
evaluate the preference for ethanol at titrated doses to determine if higher or lower 
concentrations would affect preference. Higher doses of ethanol may be aversive to mice and 
although HAP mice are selectively bred to consume large quantities of ethanol, increasing the 
dose may override this predisposition when combined with lithium treatment.   
 An unforeseen unavailability of HAP II mice precluded them from being used in 
Experiment 2. Instead of 48 HAP II mice, 36 HAP I mice were used. These mice have comparable 
rates of ethanol intake and levels of impulsivity. Subjects were separated into control chow and 
lithium chow groups and given two weeks of lithium exposure. They were then further divided 
into water and ethanol groups. At the beginning of Experiment 2, there was no significant 
difference in weights between the two groups; however mice in both lithium chow groups 
showed steady weight loss over the course of the three weeks culminating in a significant 
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difference in weights between the lithium con control chow groups at the onset of ethanol 
exposure.  
 Data collection for this experiment was sparse due to the loss of subjects; however after 
two days of ethanol exposure mice in the LE group had consumed significantly more ethanol 
then mice in the CE group. Although the LE group also consumed significantly more water than 
the CE group, it is possible that the excessive amount of ethanol intakes observed in the LE 
group may have contributed to their ill health.  
 Within one week of ethanol exposure, three of the mice in the LE group had expired and 
four more were removed due to excessive weight loss. The weights of all of the mice in the LE 
and LW groups were significantly lower than mice in the CE and CW groups, although subject 
weights in the LW group were not such that they needed to be removed from the experiment. 
There is a possibility that the combination of lithium and then ethanol exposure produced a 
toxic effect in the mice. There are two possible mechanisms driving the extreme weight loss and 
ill health seen in the mice in this experiment.  
 Lithium has never been administered to HAP I mice. Although the HAP I line is similar to 
the HAP II line in many dimensions, there may have been some unknown effect that was 
revealed through this study. Previous work with these lines has shown that they attain 
comparable weight levels and respond similarly to ethanol consumption and measures of 
impulsivity. Subjects in Experiment one of this study (HAP II mice) did not suffer from extreme 
weight loss. The fact that the mice in the LW condition also weighed less lends plausibility to this 
line of thought. Although the addition of ethanol to the cages led to death in almost all of the 
mice in the LE condition, it was not the factor contributing to the ill health of subjects in the LW 
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group. There is little information describing the exact mechanisms of action of lithium, therefore 
it is feasible that one of these mechanisms affects HAP I mice differently than HAP II mice. 
 The other possibility is that the combination and sequence of administration of lithium 
and ethanol in this experiment produced a toxic effect. Lithium has a very narrow therapeutic 
index and is toxic at moderate doses. Ho and Ho (1978) analyzed the increases in lithium toxicity 
after ethanol exposure in rats and mice. Both acute and chronic exposure to ethanol after acute 
lithium carbonate treatment led to a reduction of excretion of lithium, allowing toxic build-up in 
the system. Lithium is excreted through the renal system and subjects given lithium or ethanol 
treatment increased urine excretion; however exposure to lithium then ethanol created a 
significant decrease in urinary excretion. Many of the mice in the lithium treatment condition in 
the present experiment were exhibiting signs of lithium toxicity. Although no gastrointestinal 
effects were observed, the mice displayed poor muscle control and weakness. These effects 
were noted but not measured. Since this was not observed in Experiment one with HAP II mice, 
the negative effects seen were possibly the result of a combination of the alternate line and the 
potentiated lithium toxicity levels. This may have serious implications for treatment of bipolar 
disorder patients with comorbid alcoholism. Literature examining this phenomenon in humans 
is scarce. If the resulting toxicity is a consequence of the sequence of administration, lithium 
exposure preceding ethanol exposure, it could prove a dangerous combination for patients who 
initiate lithium treatment at an early age. 
Bipolar disorder and alcoholism are highly comorbid diseases, sharing the key 
endophenotype of heightened impulsivity (Cassidy, 2001; Holmes, 2009). Lithium is effective in 
reducing impulsivity levels in both disorders and in general symptom treatment in bipolar 
disorder (Maj, 1998; Kovsciscs, 2009; Halcomb, Gould & Grahame, in press). Although lithium is 
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effective at reducing impulsivity levels in HAP II mice and it was anticipated to reduce ethanol 
intake, the findings described here do not support the hypothesis. There are several possible 
explanations for these findings. 
First, impulsivity as a construct may be dissected into separate classifications; primarily 
cognitive impulsivity and motor impulsivity. Ohmura (2011) saw a reduction of motor impulsivity 
in mice treated with lithium and tested in the 3 choice serial reaction time task (3CSRTT). The 
3CSRTT is a method of determining motor impulsivity levels, while the delay discounting task 
used in our lab is a measure of cognitive impulsivity (Rachlin & Green, 1972). As stated above, 
our lab has found that chronic lithium treatment is effective in reducing impulsivity in the delay 
discounting task (Halcomb, Gould & Grahame, submitted, 2012). These tasks recruit alternate 
neural pathways, some of which may overlap pathways associated with ethanol intake 
(Hinshaw, 2003).  
The exact mechanisms through which lithium acts are not yet completely discerned. It 
has been associated with the inhibition of GSK-3beta, a serine/threonine kinase with varied 
functions on glycogen synthesis and neural precursor growth (Qu, 2011). Recent work in our lab 
to replicate lithium effects on impulsivity with a GSK-3beta inhibitor, have thus far yielded no 
results (Halcomb, Gould and Grahame, personal communication, 2012). Lithium effects on this 
system are still unclear. 
Lithium treatment is also correlated with more grey matter in limbic and paralimbic 
structures in bipolar patients, compared to patients receiving anticonvulsant treatment 
(Germana, 2011). There is evidence that abnormalities in these systems, primarily the amygdala, 
are involved in many of the key aspects of bipolar disorder, including impulsivity (Blond, 2012). 
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Long-term treatment with lithium may lead to increased serotonin levels in these regions, 
decreasing impulsivity (Carli, 1997).  
Also unknown are the exact mechanisms contributing to the development of alcoholism. 
There is evidence suggesting frontal cortex involvement in addiction, including the orbitofrontal 
cortex and the anterior cingulate gyrus (Goldstein, 2002). These areas show connectivity to 
limbic areas which are likely affected in patients with bipolar disorder. These regions may be 
influencing impulsivity levels in patients; however although impulsivity is a prominent aspect of 
the disorder and lithium is effective at attenuating it, the mechanism through which it is acting 
may not overlap with pathways regulating ethanol consumption. This is consistent with the 
findings of this study.  
 Second, established ethanol intake patterns in HAP mice may be highly resistant to 
reduction. Although some compounds have been shown in our lab to reduce ethanol intake 
prior to the acquisition of a consistent intake pattern, long term exposure may prevent drug 
effects. Experiment 2 was devised to determine if being treated with lithium preceding the 
establishment of a consistent drinking pattern would reduce acquisition and/or intake. Since the 
experiment was terminated, this continues to be unclear. As stated previously, HAP mice are 
selectively bred to consume high quantities of ethanol and it is possible that once they have 
acquired a high ethanol intake pattern, it is problematic to decrease it. 
Third, we did not evaluate lithium brain serum levels in this study. If lithium levels were 
not elevated enough to produce effects then that may underlie these results; however we 
believe levels were adequate. Ohmura (2011) also administered lithium through chow with 
similar means and previous work in our lab administering lithium through chow has found that 
brain serum levels were within the human therapeutic range (Halcomb, Gould & Grahame, in 
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press). Since that same chow was used in this study, it follows that comparable lithium levels 
would be achieved. 
Lastly, the polydipsia observed here may have interfered with the ability to detect 
decreases in ethanol consumption, but this seems unlikely. Although the increased thirst may 
account for the increase in ethanol intake, lithium did not affect preference. Subjects continued 
to show a significant preference for ethanol over water during Phase II lithium treatment in 
Experiment 1. A follow-up study could examine how titrating the ethanol concentration during 
lithium treatment would affect preference. Higher doses may decrease intake levels and 
preference.   
Evaluation of lithium treatment for alcoholism in human studies is often confounded by 
other concomitant disorders and may therefore be unreliable. The literature from animal 
studies indicates that while lithium chow or solution is affecting impulsivity levels in high 
alcohol-preferring subjects, there is not an effect on ethanol intake or preference. The results 
from the current study support this conclusion. The most probable conclusion is that the 
mechanism of action through which lithium is reducing impulsivity is not the driving force in 
ethanol consumption. 
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Fig 1. Timeline of Experiments. A. Procedure for Experiment one: ethanol exposure for three 
weeks followed by two weeks of lithium and ethanol exposure. B. Procedure for Experiment 
two: lithium exposure for two weeks followed by two weeks of ethanol exposure. 
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Fig 2. Total Fluid Consumption All Groups. A. During Phase I, there was no effect of group since 
all groups were consuming similar amounts. There was a main effect of day with all groups 
increasing total consumption. During Phase II, there was a significant difference between groups 
on lithium chow (LE and LW) and groups on control chow (CE and CW), F(1,42) = 11.40, p < 
0.001. There was also a main effect of day in the LE and LW groups with intakes significantly 
higher in Phase II than in Phase I for those groups, F(7,45) = 6.99, p < 0.001. B. Total fluid 
consumption in just the LE and CE groups. C. Total fluid consumption in just the LW and CW 
groups. 
 
  
29 
 
 
 
 
 
 
 
 
 
 
Fig 3. Total Fluid Intake Water Groups. A repeated measures ANOVA found a significant day X 
chow interaction on total fluid intakes in the LW and CW groups, F (7,154) = 2.134, p = 0.043. A 
follow-up t-test ascertained that by day 32 of the experiment, mice in the LW group were 
consuming significantly higher amounts of fluid than the CW group, t(22) = -2.304, p = 0.031. 
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Fig 4. Ethanol Intake Phase I. Ethanol intakes measured by g/kg/day during Phase I. There was 
no significant difference between LE and CE groups, but there was a main effect of day, with 
intakes in both groups significantly increasing during Phase I, F (9,180) = 13.12, p < 0.001. 
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Fig 5. Ethanol Preference Phase I. Both LE and CE groups significantly increased their preference 
for ethanol over water over the course of Phase I, F(9,180) = 22.97, p < 0.001. There was no 
significant difference between the two groups in preference for ethanol over water. 
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Fig 6. Ethanol Intakes Phase II. Ethanol intakes measured in g/kg/day during Phase II. There was 
a main effect of day for the LE group on ethanol intake, F(7,140) = 7.482, p < 0.001. Subjects in 
the LE group significantly increased ethanol intakes during Phase II. There was also a main effect 
of chow, with mice in the LE group consuming significantly more ethanol than subjects in the CE 
group, (1,20) = 1357.71, p < 0.001. 
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Fig 7. Ethanol Preference Phase II. Preference for ethanol over water during Phase II. There were 
no statistically significant differences between the LE and CE groups in preference for ethanol 
over water in Phase II, although there is a trend in the LE group. 
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Fig 8. Weights Experiment 1. There were no statistically significant differences between the 
groups in weight. 
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Fig 9. Ethanol Intake Experiment 2. Subjects in the LE group had significantly higher ethanol 
intakes than subjects in the CE group, t(16) = -3.342, p < 0.001. 
 
 
36 
 
 
 
 
 
 
 
 
 
 
 
 
Fig 10. Weights Experiment 2. There was a main effect of day on weight, with mice in the LE and 
LW groups decreasing in weight, F(4,136) = 10.04, p < 0.001. There was also an interaction of 
chow X day, F(4,136) = 7.64, p < 0.001 and a follow-up t-test found a significant difference 
between the lithium groups (LE and LW) and the control groups (CE and CW) by day 4 of the 
experiment, t(34) = -2.16, p = 0.04. 
